RNA - Avidity Biosciences, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - RNA (1599901)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
18 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-03-19
RNALevin Arthur ADirS - Sale+OE$23.97-5,000288,702-2%-$119,848
D
2024-03-13
RNAMaclean Michael FCFOS - Sale+OE$24.52-40,00044,093-48%-$980,760
D
2024-03-12
RNALevin Arthur ADirS - Sale+OE$22.03-27,641288,702-9%-$609,017
DM
2024-03-08
RNABoyce SarahPres, CEOS - Sale+OE$21.70-112,000112,117-50%-$2,430,392
D
2024-03-01
RNABoyce SarahPres, CEOS - Sale+OE$20.13-84,000112,117-43%-$1,691,306
2024-01-22
RNALevin Arthur ADirS - Sale$10.13-1,859291,343-1%-$18,832
D
2024-01-22
RNABoyce SarahPres, CEOS - Sale+OE$10.13-5,09244,008-10%-$51,582
D
2024-01-22
RNAFlanagan W. MichaelCSTOS - Sale+OE$10.13-4,12935,871-10%-$41,827
D
2024-01-22
RNAMcCarthy TeresaCHROS - Sale+OE$10.13-2,06517,035-11%-$20,918
D
2024-01-22
RNAMaclean Michael FCFOS - Sale+OE$10.13-1,61616,884-9%-$16,370
D
2023-03-15
RNALevin Arthur ADirS - Sale+OE$22.01-100293,2020%-$2,201
D
2023-02-14
RNALevin Arthur AChief Scientific OfficerS - Sale+OE$23.66-10,000293,202-3%-$236,567
DM
2023-02-01
RNABoyce SarahPres, CEOS - Sale+OE$24.35-50,00053,352-48%-$1,217,727
D
2023-01-12
RNALevin Arthur AChief Scientific OfficerS - Sale+OE$22.00-10,000275,202-4%-$220,028
D
2022-12-29
RNALevin Arthur AChief Scientific OfficerS - Sale+OE$22.01-40,0001,330-97%-$880,568
DM
2022-08-12
RNALevin Arthur AChief Scientific OfficerS - Sale+OE$22.10-80,000275,202-23%-$1,767,666
DM
2022-08-24
RNABoyce SarahPres, CEOS - Sale+OE$22.88-49,9000-100%-$1,141,614
D
2022-08-15
RNABoyce SarahPres, CEOS - Sale+OE$22.47-1000-100%-$2,247

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top